Q2 2025 · 13F-HR
JOHNSON & JOHNSON (JNJ)holdings as filed
Filed 2025-07-22 · accession 0000904454-25-000367
$334.1M
Reported value
20
Positions
2025-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 74366E102 | PTGX | Protagonist Therapeutics Inc. | $136.4M | 40.8% | 2,449,183 | Common | SHARED |
| G59665102 | MGTX | MeiraGTx Holdings plc | $43.9M | 13.1% | 6,641,064 | Common | SHARED |
| 75383L102 | RAPP | Rapport Therapeutics, Inc. | $28.6M | 8.55% | 2,498,051 | Common | SHARED |
| 52490G102 | LEGN | Legend Biotech Corporation | $28.2M | 8.44% | 814,586 | Common | SHARED |
| 63009J107 | NBTX | Nanobiotix S.A. | $25.5M | 7.62% | 5,623,816 | Common | SHARED |
| 126638105 | CVRX | CVRx, Inc. | $23.9M | 7.15% | 4,103,430 | Common | SHARED |
| 74276L105 | PRCT | Procept BioRobotics Corporation | $20.4M | 6.10% | 357,939 | Common | SHARED |
| 21217B100 | CTNM | Contineum Therapeutics Inc. | $8.1M | 2.43% | 1,979,173 | Common | SHARED |
| 98401F105 | XNCR | Xencor, Inc. | $6.1M | 1.82% | 748,062 | Common | SHARED |
| 04280A100 | ARWR | Arrowhead Pharmaceuticals, Inc. | $4.0M | 1.19% | 247,598 | Common | SHARED |
| 31189P102 | FATE | Fate Therapeutics, Inc. | $3.5M | 1.05% | 3,379,064 | Common | SHARED |
| 640979100 | NMRA | Neumora Therapeutics, Inc. | $1.4M | 0.42% | 1,849,445 | Common | SHARED |
| 75120L100 | — | Rallybio Corporation | $1.2M | 0.36% | 3,636,363 | Common | SHARED |
| 929033108 | — | Vor Biopharma, Inc. | $1.1M | 0.34% | 1,074,658 | Common | SHARED |
| M70700105 | NNOX | Nano-X Imaging Ltd. | $830,796 | 0.25% | 158,852 | Common | SHARED |
| 34385P108 | LAB | Standard BioTools Inc | $371,241 | 0.11% | 311,967 | Common | SHARED |
| 55083R104 | — | Lyell Immunopharma Inc. | $368,015 | 0.11% | 41,165 | Common | SHARED |
| 007002108 | TORCEUR | Adicet Bio, Inc. | $228,014 | 0.07% | 364,472 | Common | SHARED |
| 09090D103 | — | BiomX Inc. | $42,621 | 0.01% | 96,866 | Common | SHARED |
| 81727U105 | SENS1GBP | Senseonics Holdings, Inc. | $26,988 | 0.01% | 54,621 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.